Safe Biologics

The New York Academy of Sciences, in conjunction with the FDA and the National Institute for Standards and Technology (NIST), held a workshop on December 12–14, 2005 that focused on the scientific issues involved in assessing the similarity of follow-on protein products. At the conference, scientists from academe, industry, and government surveyed the scientific issues surrounding protein structure and function, focusing on specific analytical methodologies for characterizing protein products.
Read More

The State Biotechnology Industry Briefing is a PowerPoint presentation on the New York biotech industry that is made available to NYBA constituents for use in promoting the industry to a wider audience. Educators, analysts, business executives, entrepreneurs, financiers and others have used information from our industry briefings in various presentations relating to the industry.
Read More

September 19-21, 2011
Seaport World Trade Center
Boston, MA
Read More

September 19-21, 2011
Seaport World Trade Center
Boston, MA
Read More

September 7-9, 2011
Westin Boston Waterfront
Boston, MA
Read More

September 7-9, 2011
Westin Boston Waterfront
Boston, MA
Read More

June 2, 2011
Harvard Club of Boston, 374 Commonwealth Avenue
Boston, MA
Read More

March 7, 2011
Federal Reserve Bank of Boston; New England Room
Boston, MA
Read More

MassBio is front and center on Capitol Hill when it comes to advocating for policies that will pave the way for innovation. We fight for the laws and regulations that will speed the development of treatments and cures for Alzheimer’s, Diabetes, HIV/AIDs and other ailments. We work for policies that will help bring those drugs to the market and make them available to all.
Read More